Word

Status

Pending

Status Code

630

Status Date

Friday, January 5, 2024

Serial Number

98343323

Mark Type

0000

Filing Date

Friday, January 5, 2024

Trademark Owner History

Tevogen Bio Inc.

Classifications

35 Promoting innovation in the field of biotechnology through increased usage of artificial intelligence (AI) technology; promoting use of artificial intelligence (AI) technology in the field of biotechnology to expedite drug development, optimize laboratory processes, unravel complex biological data, and improve patient outcomes; promotion and advocacy services, namely promoting the advancement of biomedical, biotechnological, and immunological research and the curing of various diseases utilizing artificial intelligence (AI) technology; promotion and advocacy services, namely advocating for affordability of and increased access to medical services and the treatment of various diseases, as well as overall patient-centric medical services, utilizing artificial intelligence (AI) technology; promotion and advocacy services, namely promoting the treatment of various diseases using T cell therapies and artificial intelligence (AI) technology; promoting collaboration within the scientific, research and medical provider communities to achieve advances in the fields of biotechnology, biomedicine, immunology, immunotherapies, and T-cell therapies utilizing artificial intelligence (AI) technology; business operations consulting in the fields of biotechnology and life sciences; business operations consulting in the fields of biotechnology and life sciences to increase business processes automation and increase the efficiency of business operations procedures; database management in the fields of biotechnology and life sciences; creation, management, and analysis of databases in the fields of biotechnology and life sciences; compilation of information into computer databases in the fields of biotechnology and life sciences; collection and systematization of data through a medical device network for medical research purposes; business data analysis in the fields of biotechnology and life sciences; business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; providing an internet-based database for business purposes designed to facilitate complex statistical techniques, programming technologies and validation procedures to support clinical trials; business feasibility study planning, namely, for clinical trials; business study data interpretation, namely, for clinical trials; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval

44 Providing a website featuring news and information concerning biotechnology, biomedicine, immunology, immunotherapies, and T-cell therapies that utilize artificial intelligence (AI) technology; providing news and information concerning the prevention and treatment of oncological diseases, autoimmune diseases, neurological diseases, viral infections, and COVID-19 using artificial intelligence (AI) enabled technology; providing information concerning use of T cells and other lymphocytes for the prevention and treatment of various diseases, as enhanced by artificial intelligence (AI) technology

42 Providing a website featuring news and information concerning biomedical, biotechnological, and immunological research that utilizes artificial intelligence (AI) technology; providing news and information concerning biomedical, biotechnological, and immunological research that utilizes artificial intelligence (AI) technology; providing information concerning biomedical research into the efficacy of T cells and other lymphocytes for the prevention and treatment of various diseases, as enhanced by artificial intelligence (AI) technology; providing medical and scientific research information in the fields of T cell therapies, biologics, pharmaceuticals, and clinical trials that utilize artificial intelligence (AI) technology; providing a website featuring temporary access to non-downloadable computer software for expediting drug development, optimizing laboratory processes, and unravelling complex biological data; providing a website featuring temporary access to non-downloadable computer software for human leukocyte antigen (HLA) specificity mapping; providing a website featuring temporary access to non-downloadable computer software for protein sequences and genome matching; hosting of non-downloadable computer software for clinical trial and patient information database management; providing of non-downloadable computer software for machine learning and training of artificial intelligence models in the fields of biomedical, biotechnological, and immunological research

The mark consists of an irregular circular shape with a smaller irregular circular shape within it, with the smaller shape connected to a variety of printed electronic circuits. The mark conveys a commercial impression of the combination of a human lymphocyte cell and an electronic circuit.
Color is not claimed as a feature of the mark.

Trademark Events

Jan 5, 2024

New Application Entered